Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.200
-0.090 (-6.98%)
At close: Jun 1, 2026

Cloudbreak Pharma Statistics

Total Valuation

HKG:2592 has a market cap or net worth of HKD 1.09 billion. The enterprise value is 641.25 million.

Market Cap1.09B
Enterprise Value 641.25M

Important Dates

The next estimated earnings date is Friday, June 5, 2026.

Earnings Date Jun 5, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2592 has 844.57 million shares outstanding. The number of shares has increased by 38.15% in one year.

Current Share Class 844.57M
Shares Outstanding 844.57M
Shares Change (YoY) +38.15%
Shares Change (QoQ) +7.99%
Owned by Insiders (%) 41.32%
Owned by Institutions (%) n/a
Float 303.62M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 553.26
PB Ratio 2.31
P/TBV Ratio 2.31
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.22
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.59

Financial Position

The company has a current ratio of 10.68, with a Debt / Equity ratio of 0.01.

Current Ratio 10.68
Quick Ratio 10.09
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.01
Interest Coverage -4,659.96

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -125.66%
Return on Invested Capital (ROIC) -138.96%
Return on Capital Employed (ROCE) -176.90%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 32,282
Profits Per Employee -8.63M
Employee Count61
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax -887,312
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1.55
200-Day Moving Average 3.70
Relative Strength Index (RSI) 31.94
Average Volume (20 Days) 436,525

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2592 had revenue of HKD 1.97 million and -526.63 million in losses. Loss per share was -0.80.

Revenue1.97M
Gross Profit 1.97M
Operating Income -834.22M
Pretax Income -527.51M
Net Income -526.63M
EBITDA -832.17M
EBIT -834.22M
Loss Per Share -0.80
Full Income Statement

Balance Sheet

The company has 454.17 million in cash and 5.93 million in debt, with a net cash position of 448.24 million or 0.53 per share.

Cash & Cash Equivalents 454.17M
Total Debt 5.93M
Net Cash 448.24M
Net Cash Per Share 0.53
Equity (Book Value) 470.80M
Book Value Per Share 0.56
Working Capital 453.91M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -401.15 million and capital expenditures -1.53 million, giving a free cash flow of -402.68 million.

Operating Cash Flow -401.15M
Capital Expenditures -1.53M
Depreciation & Amortization 2.07M
Net Borrowing 971,794
Free Cash Flow -402.68M
FCF Per Share -0.48
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -42,363.25%
Pretax Margin -26,788.15%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:2592 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -38.15%
Shareholder Yield -38.15%
Earnings Yield -48.34%
FCF Yield -36.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2592 has an Altman Z-Score of 43.96 and a Piotroski F-Score of 2.

Altman Z-Score 43.96
Piotroski F-Score 2